October 6, 2017   Spain
DIAGNODE-2 clinical trial Investigator Meeting in Barcelona

Diamyd Medical arranges a two days Investigator Meeting for the European Phase II study DIAGNODE-2 attended by investigators, diabetes nurses, study managers and coordinators from Czech Republic, Sweden and Spain.
Professor Johnny Ludvigsson, Coordinating Investigator of the diabetes trial DIAGNODE-2, is leading the meeting held in Barcelona, Spain. The participants are presented to trial design, protocol and study management as a part of the preparation of the trial start and patient recruitment.

About DIAGNODE-2
The placebo controlled phase II clinical trial DIAGNODE-2 will include approximately 80 patients from Spain, the Czech Republic and Sweden aged 12-24 years, recently diagnosed with type 1 diabetes. The patients will be followed for 15 months with the aim to evaluate the remaining insulin producing capacity.

Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.

Follow Us